Skip to main content
The medtech role in the different phases of the pandemic.
Community care: Living well with dialysis at home
11 Mar 2021
Director Political Affairs at Fresenius Group & Chair of the Community Care Sector Group at MedTech Europe
Sr Director Government Policy, Advocacy & Reimbursement EMEA at Baxter & Vice-chair of the Community Care Sector Group at MedTech Europe
Providing health services in the community offers benefits to patients and can be more efficient for health systems. This was true long before any of us had...
The impact of the pandemic on people living with rare diseases
25 Feb 2021
Social Research Director - Rare Barometer Programme Lead
Almost 12 months after the WHO declared a global COVID-19 pandemic, people with rare diseases can reflect on a turbulent year – even if there are some positive...
In vitro diagnostics at risk: Covid-19 delays progresses towards the new European regulations
26 Nov 2020
Chair of the Regulatory IVD Forum of Confindustria Dispositivi Medici
In order to keep them available to the health care system and to patients, more than 85% of IVDs will need to be updated in view of the new in vitro Diagnostic...
Planning ahead – with clear data
30 Oct 2020
Kathleen Van Vlierberghe
Senior Director, Healthcare Solutions and Partnerships, EMEA at Boston Scientific
With more than 45 million confirmed cases and more than 1 million deaths at the time of writing, the coronavirus pandemic has wreaked havoc in virtually all...
COPD & COVID-19: Pandemic must prompt shift to connected care
26 Oct 2020
Vice President, EMEA Marketing at ResMed
For people living with chronic obstructive pulmonary disease (COPD), a long-term lung illness, COVID-19 is having a major impact. The pandemic has disrupted...